Kristi Rosa

More research is needed but characterizing the biologic risk factors associated with HIV that are specific to transgender women may be key to informing more effective preventive strategies.

Research suggests misperceptions about the risk of HIV infection should be corrected at the time of testing, with PrEP initiated same-day if appropriate.

International interdisciplinary collaboration will bring us that much closer to a cure for HIV.

The first global estimate of tuberculosis (TB) rates among young people find that about 1.8 million individuals in this age group develop the disease each year.

Contagion® will be providing exclusive coverage on the conference, and so, keep your eyes peeled for session coverage and interviews with some of the key presenters.

The institute has made the development of the vaccine “one of its highest priorities.”

NIAID Vaccine Research Center scientists alters broadly neutralizing HIV antibody to make it last longer in the blood.

The Michigan Department of Health and Human Services announced they are conducting an investigation of tuberculosis exposure at 3 health care facilities.

Investigators develop a statistical model predicting which bacterial strains will engraft after FMT.

FDA recommends that health care providers practice caution before prescribing clarithromycin to patients with heart disease due to potentially fatal long-term risks.

The Iowa Department of Health releases case counts associated with a Salmonella outbreak linked with chicken salad sold at Fareway stores.

The CDC have launched an investigation into a multistate outbreak of Salmonella I 4,[5],12:b:- infections that has been linked with opioid substitute kratom.

A molecule capable of clearing HSV-1 infection in the cells of the cornea could be a promising potential option for those who have developed resistance to current drugs.

Massive vaccination campaigns launched in Brazil and Nigeria strive to quell ongoing outbreaks.

Fecal transplantation and molecular testing are among the new recommendations.

ViiV Healthcare has launched a phase 3 study to assess if adults with HIV-1 who have achieved viral suppression on a 3-drug regimen can maintain suppression when switched to a 2-drug regimen.

The Rhode Island Department of Health has issued a consumer alert regarding deli sliced meat and cheese sold at a local Stop & Shop due to potential Listeria contamination.

The CDC’s acting director provides a somber flu update and stresses the need to stay vigilant against the virus.

CDC experts provide a flu update for clinicians via a COCA webinar.

The CDC’s ACIP voted to approve updated adult immunization schedule recommendations for adults aged 19 years or older.

The FDA approves Symfi Lo Tablets for the treatment of HIV-1 in adult and pediatric patients who weigh at least 35 kg.

Gilead Sciences, Inc.'s Biktarvy has been approved by the FDA for the treatment of those with HIV-1.

Grifols receives approval from the FDA for a new higher potency formulation of HyperRAB rabies immune globulin for rabies post-exposure prophylaxis.

The FDA grants Mesa Biotech Inc.'s Accula Flu A/Flu B test 510(k) clearance and CLIA waiver.

Researchers from the Wellcome Sanger Institute and collaborators find that a multidrug-resistant strain of malaria spread throughout Cambodia 5 years before clinical resistance was even reported.

Researchers from UT Health San Antonio find that exposing the gut to chlamydia protects against subsequent infection in the genital tract as well as other tissues.

The World Health Organization (WHO) released its first report on antibiotic resistance surveillance data.

The FDA grants 510(k) clearance to TECHLAB to market 2 noninvasive tests intended to aid in the diagnosis of campylobacteriosis.

With about 1 million individuals getting herpes zoster each year in the United States, the best protection against the virus is vaccination.

The FDA grants Fast Track designation to TAK-426, Takeda’s purified, inactivated, alum-adjuvanted whole Zika virus vaccine candidate.